S7 Ep2: Will the FTC Be More PBM-Friendly Under A Second Trump Administration?

Not So Different: A Podcast from The Center for Biosimilars

Show notes
To learn more about the FTC's most recent report on PBMs, click here.
To learn more about the FTC's first report on PBMs, click here.
To learn more about health care actions taken by the second Trump Administration during it's first month, click here.
To learn more about the views of Mehmet Oz, MD (more commonly known as Dr. Oz) on price transparency ahead of his congressional confirmation hearings as President Trump's nominee for HHS Secretary, click here.